Archive:
Start of implementation of the KSV Psych guideline
Social psychiatry in outpatient psychiatric and psychotherapeutic care
02.04.2023
Corona and politics: On the role of science
Comment on the start of the comment series by Prof. Dr. rer. pole. Reinhold Roski1, Prof. Dr. med. Matthias Schrappe
02.04.2023
On the role of clinical infectiology
Comment series part 1 by Prof. Dr. med. Matthias Schrappe
02.04.2023
Successful digital projects made in NRW
White paper from the “Lighthouse Digital.Medicine.NRW” initiative of the Medicine.NRW cluster
02.04.2023
For drugs for the treatment of rare diseases (orphan drugs), the requirements of early benefit assessment according to Section 35a SGB V represent a particular challenge. The Institute for Quality and Efficiency in Health Care (IQWiG) concludes in working paper GA21-01 on orphan drugs, which are in the As part of a re-evaluation of a regular benefit assessment, the additional benefit of the initial benefit assessment for market access was fictitious.
02.04.2023
Cross-sectoral community care for the elderly: The CURANDUM case study. Life expectancy in Germany has increased significantly. The proportion of single-person households is growing, as is the shortage of skilled healthcare professionals. This is offset by changes in family and care structures, as well as the desire for an active and independent retirement in one's own home. How should older people cope with these […]
02.04.2023
In rural areas, both patients and smaller hospitals have limited access to medical specialists. Teleconsultations are already established between resident doctors and clinics. The additional consultation paths presented here can reduce quality losses in small clinics, thereby strengthening the raison d'être of primary care providers and thus avoiding unnecessary, burdensome and costly double examinations.
02.04.2023
Recently published economic data show that hepatitis C therapy with direct antiviral agents (DAAs) leads to significant long-term savings in direct and indirect healthcare costs due to its curative nature. This example implies that when assessing the efficiency of innovations, it is crucial to weigh up clinical and economic short- and long-term effects in order to optimally use financial resources in the healthcare system.
02.04.2023
Longitudinal analysis of psoriasis, rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and chronic bowel disease
Course of the disease and use of medication in chronic inflammatory diseases in Germany
02.04.2023
“We need experimental spaces for health services research”
Professor Josef Hecken, the impartial chairman of the Federal Joint Committee and chairman of the Innovation Committee, underlined his suggestions for the further development of the innovation fund, which he presented in the cover interview of the MVF issue (06 /22) and in his lecture in the first part of the MVF specialist congress “Prioritisation Catalog for Health Care Research”. The new CEO of the DNVF, Prof. Dr. Wolfgang Hoffmann, and Prof. Dr. Bertram Häussler, the chairman of the board of the Berlin IGES Institute, joined forces as intellectual sparring partners to put Hecken's demands through their paces in the joint cover interview with "Monitor Healthcare Research".